DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4
El-Halawani, N., Neanaa, E., ElSabaa, B., Abo Elwafa, R., Ogechi, P. (2023). DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4. EKB Journal Management System, 5(4), 26-27. doi: 10.21608/alexpo.2023.245342.1719
Nabil Ahmed El-Halawani; Eman Hashem Mohamed Neanaa; Basma Mohamed ElSabaa; Reham Abdel Haleem Abo Elwafa; Phelisters Nyaboke Ogechi. "DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4". EKB Journal Management System, 5, 4, 2023, 26-27. doi: 10.21608/alexpo.2023.245342.1719
El-Halawani, N., Neanaa, E., ElSabaa, B., Abo Elwafa, R., Ogechi, P. (2023). 'DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4', EKB Journal Management System, 5(4), pp. 26-27. doi: 10.21608/alexpo.2023.245342.1719
El-Halawani, N., Neanaa, E., ElSabaa, B., Abo Elwafa, R., Ogechi, P. DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4. EKB Journal Management System, 2023; 5(4): 26-27. doi: 10.21608/alexpo.2023.245342.1719

DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4

ALEXMED ePosters
Article 1, Volume 5, Issue 4, December 2023, Page 26-27  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.245342.1719
View on SCiNiTO View on SCiNiTO
Authors
Nabil Ahmed El-Halawani1; Eman Hashem Mohamed Neanaa2; Basma Mohamed ElSabaa3; Reham Abdel Haleem Abo Elwafa4; Phelisters Nyaboke Ogechi email 5
1Department of internal medicine , Faculty of Medicine, Alexandria University, Alexandria, Egypt
2Department of Critical Care Medicine, Faculty of Medicine. Alexandria University Alexandria Egypt
3Department of Pathology, Faculty of Medicine, Alexandria University
4clinical pathology, faculty of medicine , Alexandria
5Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Abstract
Notch pathway has been reported to have both oncogenic and tumor suppressor roles, dependent on the cancer cell type. It is an evolutionally conserved signaling pathway, consisting a family of transmembrane receptors. These notch receptors will communicate and regulate other cells, which have a specific ligand for their receptors. This highly coordinated signaling system controls many aspects of cell biology including differentiation, proliferation and death.
Notch-2 gene mutation causes deregulation of the signaling pathways such as notch2 receptor and IL-2 receptor (Toll- like receptor) these will lead to increased activation of nuclear factor kappa B (NFκB), which leads to increased survival of malignant cells.
The notch inhibitors in malignant cells have the potential to slow cell proliferation, cause apoptosis and induce differentiation. These effects are surprisingly given an extensive cross- through of notch with major malignant pathways such as NFκB, Ras and Akt. Notch pathway is a particularly powerful target of tumor stem cell subsets, that is resistant to standard therapy
Keywords
Notch-2; gene; mutation
Supplementary Files
Statistics
Article View: 15